Hao Zhao

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Ejection Fraction

Disease Activity

Acute Lymphoblastic Leukemia

Multiple Myeloma

Top Venues

International journal of hematology

Annals of hematology

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yan-Ting Liu, Yu-Han Gao, Hao Zhao, Miao-Yan Zhang, Ming-Hui Duan, Jian Li, Lu Zhang
Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study. Annals of hematology (2024)
Lu Zhang, Yu-Han Gao, Si-Yuan Li, Hao Zhao, Miao-Yan Zhang, Yan-Ying Yu, Yan-Ting Liu, Jian Li
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease. International journal of hematology (2024)
Lu Zhang, Yu-Han Gao, Si-Yuan Li, Hao Zhao, Miao-Yan Zhang, Yan-Ying Yu, Yan-Ting Liu, Jian Li
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease. International journal of hematology 119 (6) (2024)
Hao Zhao, Miao-Yan Zhang, Kai-Ni Shen, Jun Feng, Xin-Xin Cao, Ming-Hui Duan, Dao-Bin Zhou, Lu Zhang, Jian Li
A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in newly-diagnosed iMCD patients. Blood (2023)
Hao Zhao, Xue-Min Gao, Xin-Xin Cao, Lu Zhang, Dao-Bin Zhou, Jian Li
Revealing serum lipidomic characteristics and potential lipid biomarkers in patients with POEMS syndrome. Journal of cellular and molecular medicine 25 (9) (2021)